These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 843620)

  • 1. Demonstration and mode of action of an inhibitor for activated Hageman factor (factor XIIa) of the intrinsic blood coagulation pathway from Schistosoma mansoni.
    Tsang VC; Damian RT
    Blood; 1977 Apr; 49(4):619-33. PubMed ID: 843620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation factor XIIa (activated Hageman factor) inhibitor from adult Schistosoma mansoni.
    Tsang VC; Hubbard WJ; Damian RT
    Am J Trop Med Hyg; 1977 Mar; 26(2):243-7. PubMed ID: 848647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni.
    Foster CB; Flanigan TP; DeStigter KK; Blanton R; Dumenco LL; Gallagher C; Ratnoff OD
    J Lab Clin Med; 1992 Nov; 120(5):735-9. PubMed ID: 1431502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation.
    MacQuarrie JL; Stafford AR; Yau JW; Leslie BA; Vu TT; Fredenburgh JC; Weitz JI
    Blood; 2011 Apr; 117(15):4134-41. PubMed ID: 21304106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of factor XI in plasma is dependent on factor XII.
    Brunnée T; La Porta C; Reddigari SR; Salerno VM; Kaplan AP; Silverberg M
    Blood; 1993 Feb; 81(3):580-6. PubMed ID: 8427954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system.
    Berrettini M; Schleef RR; España F; Loskutoff DJ; Griffin JH
    J Biol Chem; 1989 Jul; 264(20):11738-43. PubMed ID: 2787318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen.
    Mandle RJ; Kaplan AP
    Blood; 1979 Oct; 54(4):850-62. PubMed ID: 89876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets and initiation of intrinsic clotting.
    Schiffman S; Rapaport SI; Chong MM
    Br J Haematol; 1973 May; 24(5):633-42. PubMed ID: 4712832
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa.
    Baglia FA; Walsh PN
    J Biol Chem; 2000 Jul; 275(27):20514-9. PubMed ID: 10781579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lupus inhibitor: a study of its heterogeneity.
    Coots MC; Miller MA; Glueck HI
    Thromb Haemost; 1981 Dec; 46(4):734-9. PubMed ID: 7330826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional characterization of factor XII.
    Tans G; Rosing J
    Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay.
    Scott CF; Sinha D; Seaman FS; Walsh PN; Colman RW
    Blood; 1984 Jan; 63(1):42-50. PubMed ID: 6606454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI).
    Ratnoff OD
    J Lab Clin Med; 1972 Nov; 80(5):704-10. PubMed ID: 4673237
    [No Abstract]   [Full Text] [Related]  

  • 16. The human plasma kinin system. II. Contact activation of plasma prekallikrein and factor XI in factor XII-deficiency plasma.
    Ozge-Anwar AH; Movat HZ; Scott JG
    Proc Soc Exp Biol Med; 1971 Oct; 138(1):330-7. PubMed ID: 4108176
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor).
    Kurachi K; Davie EW
    Biochemistry; 1977 Dec; 16(26):5831-9. PubMed ID: 588558
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of the activation of Hageman factor (factor XII) and of platelet aggregation by extracts of Brugia malayi microfilariae.
    Foster CB; Flanigan TP; Kazura JW; Dumenco LL; Ratnoff OD
    J Lab Clin Med; 1991 May; 117(5):344-52. PubMed ID: 1902251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
    Griffin JH; Cochrane CG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate.
    Scott CF; Colman RW
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11189-93. PubMed ID: 1454798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.